376 related articles for article (PubMed ID: 25771165)
1. Recent advances in atopic dermatitis and psoriasis: genetic background, barrier function, and therapeutic targets.
Miyagaki T; Sugaya M
J Dermatol Sci; 2015 May; 78(2):89-94. PubMed ID: 25771165
[TBL] [Abstract][Full Text] [Related]
2. The translational revolution and use of biologics in patients with inflammatory skin diseases.
Noda S; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Feb; 135(2):324-36. PubMed ID: 25541257
[TBL] [Abstract][Full Text] [Related]
3. Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.
Guttman-Yassky E; Krueger JG; Lebwohl MG
Exp Dermatol; 2018 Apr; 27(4):409-417. PubMed ID: 28266782
[TBL] [Abstract][Full Text] [Related]
4. Facing psoriasis and atopic dermatitis: are there more similarities or more differences?
Wilsmann-Theis D; Hagemann T; Jordan J; Bieber T; Novak N
Eur J Dermatol; 2008; 18(2):172-80. PubMed ID: 18424378
[TBL] [Abstract][Full Text] [Related]
5. So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis.
Schäbitz A; Eyerich K; Garzorz-Stark N
J Intern Med; 2021 Jul; 290(1):27-39. PubMed ID: 33428274
[TBL] [Abstract][Full Text] [Related]
6. Contrasting pathogenesis of atopic dermatitis and psoriasis--part I: clinical and pathologic concepts.
Guttman-Yassky E; Nograles KE; Krueger JG
J Allergy Clin Immunol; 2011 May; 127(5):1110-8. PubMed ID: 21388665
[TBL] [Abstract][Full Text] [Related]
7. [Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis].
Villarrubia VG; Vidal-Asensi S; Pérez-Bañasco V; Cuevas-Santos J; Cisterna-Cáncer R
Actas Dermosifiliogr; 2010 Sep; 101(7):585-99. PubMed ID: 20858385
[TBL] [Abstract][Full Text] [Related]
8. Skin Barrier Function and Allergens.
Engebretsen KA; Thyssen JP
Curr Probl Dermatol; 2016; 49():90-102. PubMed ID: 26844901
[TBL] [Abstract][Full Text] [Related]
9. Advances in the pathophysiology of atopic dermatitis revealed by novel therapeutics and clinical trials.
Yang X; Kambe N; Takimoto-Ito R; Kabashima K
Pharmacol Ther; 2021 Aug; 224():107830. PubMed ID: 33662453
[TBL] [Abstract][Full Text] [Related]
10. Epidermal expression of host response genes upon skin barrier disruption in normal skin and uninvolved skin of psoriasis and atopic dermatitis patients.
de Koning HD; Kamsteeg M; Rodijk-Olthuis D; van Vlijmen-Willems IM; van Erp PE; Schalkwijk J; Zeeuwen PL
J Invest Dermatol; 2011 Jan; 131(1):263-6. PubMed ID: 20861857
[No Abstract] [Full Text] [Related]
11. The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis.
Cheng T; Tjabringa GS; van Vlijmen-Willems IM; Hitomi K; van Erp PE; Schalkwijk J; Zeeuwen PL
Br J Dermatol; 2009 Aug; 161(2):253-64. PubMed ID: 19438477
[TBL] [Abstract][Full Text] [Related]
12. Epidermal barrier in hereditary ichthyoses, atopic dermatitis, and psoriasis.
Schmuth M; Blunder S; Dubrac S; Gruber R; Moosbrugger-Martinz V
J Dtsch Dermatol Ges; 2015 Nov; 13(11):1119-23. PubMed ID: 26513068
[TBL] [Abstract][Full Text] [Related]
13. New pathogenic and therapeutic paradigms in atopic dermatitis.
Malajian D; Guttman-Yassky E
Cytokine; 2015 Jun; 73(2):311-8. PubMed ID: 25542094
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis.
Nomura I; Gao B; Boguniewicz M; Darst MA; Travers JB; Leung DY
J Allergy Clin Immunol; 2003 Dec; 112(6):1195-202. PubMed ID: 14657882
[TBL] [Abstract][Full Text] [Related]
15. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
Kaufman BP; Alexis AF
Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms in atopic dermatitis.
Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
[TBL] [Abstract][Full Text] [Related]
17. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
Czarnowicki T; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
[TBL] [Abstract][Full Text] [Related]
18. An Update on the Pathophysiology of Atopic Dermatitis.
Malik K; Heitmiller KD; Czarnowicki T
Dermatol Clin; 2017 Jul; 35(3):317-326. PubMed ID: 28577801
[TBL] [Abstract][Full Text] [Related]
19. In vivo expression of antimicrobial peptides in atopic dermatitis.
Clausen ML; Slotved HC; Krogfelt KA; Andersen PS; Agner T
Exp Dermatol; 2016 Jan; 25(1):3-9. PubMed ID: 26269388
[TBL] [Abstract][Full Text] [Related]
20. Prostanoids and leukotrienes in the pathophysiology of atopic dermatitis and psoriasis.
Honda T; Kabashima K
Int Immunol; 2019 Aug; 31(9):589-595. PubMed ID: 30715370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
